Jalaja Joseph, MD

Dr. Jalaja Joseph is a board-certified Internal Medicine physician with fellowship training in Endocrinology, diabetes, and metabolism. She graduated from Mysore Medical College, Rajiv Gandhi University of Health Sciences Karnataka in Bengaluru, India, in 2005. She completed her Internal Medicine residency at Queens Hospital Center, Icahn School of Medicine at Mount Sinai in New York in 2011. Dr. Joseph completed a fellowship in Endocrinology and Metabolism at the National Institutes of Health in Bethesda, Md., in 2014. Prior to joining Kelsey-Seybold in March 2022, Dr. Joseph was assistant professor in the Department of Medicine, Division of Endocrinology at Albany Medical Center for seven years.

Dr. Joseph is a member of the Endocrine Society and the American Association of Clinical Endocrinology.

Dr. Joseph loves spending time with her kids and doing activities with them. She also enjoys reading and likes to cook.

Fun Facts

The best advice Dr. Joseph has received is “Never look back on your decisions and move forward” and “Worry only about things that you can control.”

Not everyone knows this about her, but she loves humor!

Publications

• Leinung MC, Feustel PJ, Joseph J. Changing Demographics in Transgender Individuals Seeking Hormonal Therapy: Are Trans Women More Common Than Trans Men. Transgender Health. June 2020
• Leinung MC, Miller CH, Tehrani B, Joseph J. The Effect of Efavirenz on Estradiol Metabolism in Transgender Women. Transgender Health. Sept 2019
• Leinung MC, Feustel PJ, Joseph J. Hormonal Treatment of Transgender Women With Oral Estradiol. Transgender Health. May 2018
• Ahmad S, Joseph J. VISUAL VIGNETTE. Endocrine Practice: December 2017
• Brown RJ, Joseph J, Cochran E, Gewert C, Semple R, Gorden P. Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis. Journal of Clinical Endocrinology and Metabolism. June 2017
• Sachmechi I, Ahmed S, Joseph J, Reich D, Cardinal L, et al. Effect of Alendronate on Bone Mineral Density in Post-Menopausal Women with Type 2 Diabetes Mellitus. Int J Endocrinol Metab Disord. May 2015
• Joseph J, Shamburek RD, Cochran E, Gorden P, Brown RJ. Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation of HDL-C and triglycerides. Journal of Clinical Endocrinology and Metabolism. June 2014
• Muniyappa R, Brown RJ, Mari A, Joseph J et al. Effects of Leptin Replacement Therapy on Pancreatic beta-Cell Function in Patients with Lipodystrophy. Diabetes care. Feb 2014
• Masood W, Joseph J, Bandagi S. Acute Rheumatic Fever (Arf) With Coincident Poststreptococcal Glomerulonephritis (PSGN) in an Adult: A Case Report and Review of Literature. American Journal of Kidney Diseases. Apr 2011
• Dharshan AC, Joseph J, Goel SK, Tavakoly A, Shenoy MM. Double interatrial septum. Canadian Journal of Cardiology. Feb 2010

Presentations

• Trovato A, Nguyen S, Leinung MC, Joseph J: Achieving Physiologic 17-ẞ-Estradiol Levels in Transgender Females on Estradiol Transdermal Patches and Optimal Dosing. September 2020, Medical Student Investigation Day, Albany Medical Center
• Leinung MC, Joseph J: Changing Demographics in Transgender Individuals Seeking Hormonal Therapy: Are Trans Women More Common Than Trans Males? March 2018, Endocrine Society, Chicago
• Kafrouni A, Joseph J, Venous Thromboembolism in Male-to-Female Transgender Patients on Oral Estradiol: A Case Series: March 2018, Endocrine Society, Chicago
• Leinung MC, Miller C, Joseph J: Impact of Efavirenz on Estradiol Metabolism: March 2018, Endocrine Society, Chicago
• Joseph J, Zhang R, Jou S, Conti D, Leinung MC: Endocrine management of renal transplant patients: A role in successful graft survival. April 2017, Endocrine Society, Florida
• Ahmad S, Lee JH, Park E, Leinung MC, Joseph J: Ectopic ACTH Co-Secretion and Adrenal Pheochoromocytoma from a 11 cm Adrenal Mass April 2016, Endocrine Society, Boston
• Ahmad S, Kim S, Joseph J, Leinung MC: A Cross- Sectional Study of Clinical and Psychosocial Characteristics of a Cohort of 371 Transgender Patients Treated at Albany Medical Center April 2016, Endocrine Society, Boston
• Kim GY, Kim CS, Jennings T, Joseph J: Papillary Thyroid Carcinoma Arising in a Thyroglossal Duct Cyst: A Case Report October 2015, American Thyroid Association, Florida
• Joseph J, Cochran EK, Gorden P, Brown RJ: Pubertal Gonadotropins Are Required for Insulin-Induced Hyperandrogenism. June 2014, American Diabetes Association, California
• Joseph J, Stratakis C, et al. Bleeding Adrenal: Adrenal Hemorrhage as a Complication of Adrenal Venous Sampling. June 2013, Endocrine Society, California
• Joseph J, Gorden P et al. Enigma of low levels of high-density lipoproteins in Lipodystrophy June 2013, Endocrine Society, California
• Joseph J, Skarulis M, et al. Retroperitoneal Mass, Hypopituitarism, Thyroiditis and Auricular ossification: Possible IgG4-Related Disease. June 2013, Endocrine Society, California
• Sullivan S, Muniyappa R. Joseph J, et al. Effects of Growth Hormone and Testosterone Administration on Thyroid Function in Healthy Older Men. June 2012, Endocrine Society, Texas
• Joseph J, Bandagi S, et al. Paraneoplastic Anti-CCP Antibody Positive Polyarthritis May Mimic Rheumatoid Arthritis. Second position in the clinical vignette category. November 2010, AMA, California
• Joseph J, Sachemechi I, et al. Effect of Diabetes on Bone Mineral Density in Post-Menopausal Women on Alendronate Therapy. June 2010, Mount Sinai Medical Center, NY
• Joseph J, Abrudescu A, et al. A Case of Pulmonary Cryptococcosis in Polymyositis June 2010, Mount Sinai Medical Center, NY
• Joseph J, Shenoy M, et al. Cardiac Tumor or Just Fat? May 2010, Queens Hospital Center, NY
• Joseph J, Ahmed S, et al. Left atrial Myxoma masquerading as pulmonary tuberculosis November 2009, AMA, Texas

Research

• A Multicenter, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add On to Insulin Therapy in Subjects with Type 1 Diabetes Mellitus- Sub Investigator- Industry Sponsored Trial: November 2015 – April 2018
• BROADEN STUDY. A Randomized, Double Blind, Placebo-Controlled, Phase 2/3 Study of ISIS 304801 Administered Subcutaneously to Patients with Partial Lipodystrophy – Principal Investigator-Industry Sponsored Trial. December 2015 – August 2017